Close

Dr Patrick Bidulka

Assistant Professor

United Kingdom

I am an epidemiologist and health data scientist with expertise in using routinely collected health data for causal inference.

I completed my PhD and MSc in epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM), and my BSc in pharmacology and economics at McGill University in Montréal, Canada.

Prior to joining the LSHTM, I worked at McGill Global Health Programs and the Population Health Research Institute (PHRI) in Hamilton, Canada. I continue to collaborate with researchers at PHRI.

Affiliations

Department of Health Services Research and Policy
Faculty of Public Health and Policy

Teaching

I am a module organiser and lecturer for the Analysis of Electronic Health Records module (open to MSc Health Data Science, Epidemiology, and Public Health students).

I also teach on the following MSc modules and short courses:

  • Health Services
  • Extended Epidemiology
  • Advanced Research Methods in Epidemiology
  • Statistical Methods in Epidemiology
  • Epidemiology in Practice
  • Professional Certificate in Pharmacoepidemiology & Pharmacovigilance

I supervise PhD and MSc students (Epidemiology, Medical Statistics, Health Data Science, and Public Health) in subjects related to health services research and causal inference using electronic health records. 

I also co-lead and supervise for the Health Data Research (HDR)-UK Black Internship Programme at LSHTM, which aims to reduce the underrepresentation of Black people within the health data science sector.

Research

My research focuses on using electronic health record data to study the comparative clinical and cost-effectiveness of treatments for non-communicable diseases.

I am a member of the Electronic Health Records research group at the LSHTM and collaborate on many projects with my teammates. I work across faculties at the LSHTM (Epidemiology & Population Health (EPH) and Public Health & Policy (PHP)), as well as with an international group of epidemiologists, statisticians, health economisits, clinicians, and patients.

I am involved in several observational studies applying instrumental variable analyses to estimate causal treatment effects. These studies mainly use routinely collected health data from the UK, including primary care data (e.g., Clinical Practice Research Datalink), secondary care data (e.g., Hospital Episode Statistics), and clinical audit data (e.g., National Vascular Registry).

I am also involved in projects using electronic health records and other routine data in Thailand, Denmark, and Sweden. 

I have worked on several projects during my time at the LSHTM related to health services and pharmacoepidemiology focused on the intersection between type 2 diabetes, cardiovascular, and kidney disease. These projects include:

Research Area
Electronic health records
Health inequalities
Health outcomes
Health services research
Pharmacovigilance
Implementation science
Disease and Health Conditions
Diabetes
Kidney disease
Mental health
Non-communicable diseases
Stroke
Cardiovascular diseases
Country
Canada
Denmark
India
Rwanda
South Africa
Uganda
United Kingdom
Thailand
Region
European Union
North America
Sub-Saharan Africa (all income levels)

Selected Publications

Enhancing evidence-based care using trial emulation in electronic health records: real-world effects of empagliflozin in people with type 2 diabetes.
Ryan, DK; KEOGH, RH; WILLIAMSON, E; Lumbers, RT; Diaz-Ordaz, K; Shah, AD; BIDULKA, P;
2026
BMJ open diabetes research & care
Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data.
O'NEILL, S; BIDULKA, P; Lugo-Palacios, DG; CARROLL, O; Leiva-Escobar, I; Silverwood, R; BRIGGS, A; Adler, AI; Khunti, K; GRIEVE, R;
2025
Diabetologia
Long-term outcomes following alternative second-line oral glucose-lowering treatments: Results from the real-world progression in type 2 diabetes mellitus United Kingdom (RAPIDS-UK) model.
CARROLL, OU; BIDULKA, P; Basu, A; Adler, AI; O'NEILL, S; BRIGGS, AH; Lugo-Palacios, DG; Khunti, K; GRIEVE, R;
2025
Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations.
Lugo-Palacios, DG; BIDULKA, P; O'NEILL, S; CARROLL, O; Basu, A; Adler, A; DíazOrdaz, K; BRIGGS, A; GRIEVE, R;
2024
Health economics
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
BIDULKA, P; Lugo-Palacios, DG; CARROLL, O; O'NEILL, S; Adler, AI; Basu, A; Silverwood, RJ; BARTLETT, JW; NITSCH, D; Charlton, P; BRIGGS, AH; SMEETH, L; DOUGLAS, IJ; Khunti, K; GRIEVE, R;
2024
BMJ
Management and outcomes of myocardial infarction in people with impaired kidney function in England.
Scott, J; BIDULKA, P; Taylor, DM; Udayaraj, U; Caskey, FJ; Birnie, K; Deanfield, J; De Belder, M; Denaxas, S; Weston, C; Adlam, D; NITSCH, D;
2023
BMC nephrology
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform.
COSTELLO, RE; Tazare, J; Piehlmaier, D; HERRETT, E; Parker, EP K; ZHENG, B; Mansfield, KE; HENDERSON, AD; CARREIRA, H; BIDULKA, P; Wong, AY S; WARREN-GASH, C; Hayes, JF; Quint, JK; MacKenna, B; Mehrkar, A; EGGO, RM; Katikireddi, SV; TOMLINSON, L; LANGAN, SM; Mathur, R; LH&W NCS (or CONVALESCENCE) Collaborative,; OpenSAFELY collaborative,;
2023
EClinicalMedicine
Ethnic and socioeconomic disparities in initiation of second-line antidiabetic treatment for people with type 2 diabetes in England: A cross-sectional study.
BIDULKA, P; Mathur, R; Lugo-Palacios, DG; O'NEILL, S; Basu, A; Silverwood, RJ; Charlton, P; BRIGGS, A; SMEETH, L; Adler, AI; DOUGLAS, IJ; Khunti, K; GRIEVE, R;
2022
Diabetes, obesity & metabolism
Impact of chronic kidney disease on case ascertainment for hospitalised acute myocardial infarction: an English cohort study.
BIDULKA, P; Scott, J; Taylor, DM; Udayaraj, U; Caskey, F; Teece, L; Sweeting, M; Deanfield, J; De Belder, M; Denaxas, S; Weston, C; Adlam, D; NITSCH, D;
2022
BMJ Open
See more information